Esperer Nutrition’s journey from ideation to commercialization in developing the ES Invigour brand, a clinical nutrition solution for cancer patients.
Conducted a comprehensive review of ingredients and bioactives used in chemotherapy support, focusing on maintaining nutritional balance.
Identified and combined the most effective nutrients and bioactives to enhance therapy support.
Examined the pathways of various bioactives, assessing their combination efficacy.
Developed a unique matrix combining MCT oils with selected bioactives to optimize nutritional support during chemotherapy.
Established a robust supply chain network and secured necessary investment resources for production and distribution.
Successfully introduced FORTITUDE, a specialized clinical nutrition brand for cancer patients.
Achieved seamless integration from conceptualization to market, backed by a solid investor base and an efficient supply chain.
Esperer Nutrition’s FORTITUDE represents a landmark in clinical nutrition, offering tangible support to cancer patients during chemotherapy. This case study demonstrates the power of AI-driven solutions, strategic operational execution, and the importance of targeted nutritional supplementation in healthcare.

